Harmony Biosciences (NASDAQ:HRMY) Shares Gap Down Following Analyst Downgrade
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) gapped down before the market opened on Wednesday after Mizuho lowered their price target on the stock from $52.00 to $42.00. The stock had previously closed at $39.09, but opened at $36.82. Mizuho currently has an outperform rating on the stock. Harmony Biosciences shares last traded […]
